Traditional Scraping (Gua Sha) Combined with Copper‐Curcumin Nanoparticle Oleogel for Accurate and Multi‐Effective Therapy of Androgenic Alopecia
Source abstract
Abstract
Abstract Androgenetic alopecia (AGA) is a prevalent systemic disease caused by diverse factors, for which effective treatments are currently limited. Herein, the oleogel (OG) containing copper‐curcumin (CuR) nanoparticles is developed, designated as CuRG, which is also combined with traditional naturopathic scraping (Gua Sha, SCR) as a multifunctional therapy for AGA. With the assistance of lipophilic OG and SCR, CuR can efficaciously penetrate the epidermal and dermal regions where most hair follicles (HFs) reside, thereby releasing curcumin (CR) and copper ions (Cu2+) subcutaneously to facilitate hair regeneration. Concomitantly, the mechanical stimulation induced by SCR promotes the formation of new blood vessels, which is conducive to reshaping the microenvironment of HFs. This study validates that the combination of CuRG and SCR is capable of systematically interfering with different pathological processes, ranging from improvement of perifollicular microenvironment (oxidative stress and insufficient vascularization), regulation of inflammatory responses to degradation of androgen receptor, thus potentiating hair growth. Compared with minoxidil, a widely used clinical drug for AGA therapy, the designed synergistic system displays augmented hair regeneration in the AGA mouse model.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hair Growth and Disorders · Wound Healing and Treatments · Skin Protection and Aging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The National Engineering Research Center for Bioengineering Drugs and the Technologies Institute of Translational Medicine Nanchang University Nanchang 330088 China
School of Chemistry and Chemical Engineering Nanchang University Nanchang 330088 China
Funding
Key Research and Development Program of Jiangxi Province
References (54)
Show source-provided references
1. 10.1016/j.actbio.2022.02.02510.1016/j.actbio.2022.02.025 ↗
2. 10.1002/adhm.20220090810.1002/adhm.202200908 ↗
3. 10.1111/jdv.1707910.1111/jdv.17079 ↗
4. 10.1038/s41467-017-01490-810.1038/s41467-017-01490-8 ↗
5. 10.1021/acsnano.1c0527210.1021/acsnano.1c05272 ↗
6. Zhang Z. W. B. · Bioact. Mater. · 2022 · 24 · 81
7. 10.1002/smtd.20220129310.1002/smtd.202201293 ↗
8. 10.1016/j.jaad.2017.02.05410.1016/j.jaad.2017.02.054 ↗
9. 10.1111/jdv.1762310.1111/jdv.17623 ↗
10. 10.1007/s13346-017-0447-710.1007/s13346-017-0447-7 ↗
11. 10.1136/bmj.l504710.1136/bmj.l5047 ↗
12. 10.1038/s41467-020-19249-z10.1038/s41467-020-19249-z ↗
13. 10.1016/j.jddst.2022.10358310.1016/j.jddst.2022.103583 ↗
14. 10.1016/j.jep.2015.11.01210.1016/j.jep.2015.11.012 ↗
15. 10.1002/adfm.20170714010.1002/adfm.201707140 ↗
16. 10.1002/mnfr.20110032810.1002/mnfr.201100328 ↗
17. 10.1002/adhm.20200052710.1002/adhm.202000527 ↗
18. 10.1007/s12274-021-3864-310.1007/s12274-021-3864-3 ↗
19. 10.1016/j.cej.2020.12627310.1016/j.cej.2020.126273 ↗
20. 10.1016/j.colcom.2018.04.00910.1016/j.colcom.2018.04.009 ↗
21. 10.1016/j.biomaterials.2021.12085310.1016/j.biomaterials.2021.120853 ↗
22. 10.1002/adma.20220898910.1002/adma.202208989 ↗
23. 10.1002/adhm.20230088110.1002/adhm.202300881 ↗
24. 10.1002/adfm.20200425710.1002/adfm.202004257 ↗
25. 10.1111/1541-4337.1296610.1111/1541-4337.12966 ↗
26. 10.2174/15672011079101176510.2174/156720110791011765 ↗
27. 10.1016/j.bioactmat.2022.11.01510.1016/j.bioactmat.2022.11.015 ↗
28. 10.1038/s41467-021-20948-410.1038/s41467-021-20948-4 ↗
29. 10.1016/j.apmt.2021.10118810.1016/j.apmt.2021.101188 ↗
30. 10.7717/peerj.245110.7717/peerj.2451 ↗
31. 10.1016/j.ijpharm.2017.01.00710.1016/j.ijpharm.2017.01.007 ↗
32. 10.1038/s41467-019-09402-810.1038/s41467-019-09402-8 ↗
33. 10.1098/rsif.2022.036010.1098/rsif.2022.0360 ↗
34. 10.1016/j.jiec.2020.08.01110.1016/j.jiec.2020.08.011 ↗
35. 10.1016/j.fbio.2018.03.00710.1016/j.fbio.2018.03.007 ↗
36. 10.1021/acsami.2c0294910.1021/acsami.2c02949 ↗
37. Barik A. · Biol. Med. · 2005 · 39 · 811
38. 10.1016/j.snb.2017.06.14910.1016/j.snb.2017.06.149 ↗
39. 10.1021/acscentsci.1c0086610.1021/acscentsci.1c00866 ↗
40. 10.1016/j.carbpol.2023.12066810.1016/j.carbpol.2023.120668 ↗
41. 10.1016/j.cej.2019.12227210.1016/j.cej.2019.122272 ↗
42. 10.1002/app.3750610.1002/app.37506 ↗
43. 10.1021/acs.nanolett.2c0311910.1021/acs.nanolett.2c03119 ↗
44. 10.1021/acsnano.1c1057510.1021/acsnano.1c10575 ↗
45. 10.1002/adma.20210573810.1002/adma.202105738 ↗
46. 10.1002/adma.20220507210.1002/adma.202205072 ↗
47. 10.1016/j.ijpharm.2023.12309010.1016/j.ijpharm.2023.123090 ↗
48. 10.1002/adfm.20220563410.1002/adfm.202205634 ↗
49. 10.1016/j.jconrel.2022.08.00710.1016/j.jconrel.2022.08.007 ↗
50. 10.1111/dth.1235510.1111/dth.12355 ↗
51. 10.1002/adma.20220620010.1002/adma.202206200 ↗
52. 10.1007/s10103-017-2224-810.1007/s10103-017-2224-8 ↗
53. Tong G. J. · Oncol. Rep. · 2020 · 43 · 1187
54. Figueiredo C. C. · Histol. Histopathol. · 2019 · 34 · 257